No Data
Unity Biotechnology Focuses on Promising DME Treatment
Unity Biotechnology GAAP EPS of -$0.38 Beats by $0.02
Express News | Unity Biotechnology Q3 2024 GAAP EPS $(0.38) Beats $(0.40) Estimate
Unity Biotechnology | 10-Q: Q3 2024 Earnings Report
Unity Biotechnology | 8-K: UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
Express News | UNITY Biotechnology Inc: UNITY Expects Topline 24-Week Primary Endpoint Data in Q1 of 2025 and 36-Week Data in Q2 of 2025